大都会人寿
MET
100.76
+0.49
+0.49%
大都会人寿
US · MET
#367 按市值排名
上市于 2000
100.76
+0.49
+0.49%
实时 - 追踪5344个代码 - 心跳于551秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 最近一期(2026/Q3)披露持股的机构数量减少了5家。
- 机构持股总比例基本持平。
机构持股
- 机构持股比例
- 93.98% -0.03pp
- 机构数量
- 1,674 -5
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期减持了股份,同时该股在最近20个交易日的主力资金呈净流入——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。
持股人类型
Mutual Fund67.11%
Private Company17.60%
Public Company3.68%
Government Pension Fund1.94%
Hedge Fund1.83%
Sovereign Wealth Fund1.12%
Individual/Insider0.24%
Family Office/Trust0.21%
Insurance Company0.21%
Other6.05%
主要股东 截至 2026-08-06
MetLife Policyholder Trust
16.07% · 102.10M 股
BlackRock
8.15% · 51.79M 股
Dodge & Cox
7.62% · 48.43M 股
Vanguard Capital Management, LLC
6.06% · 38.52M 股
Vanguard Portfolio Management, LLC
4.73% · 30.03M 股
Other
57.38%
State Street Global Advisors
3.99% · 25.34M 股
T. Rowe Price Group, Inc.
3.35% · 21.28M 股
Geode Capital Management, LLC
2.09% · 13.31M 股
Pzena Investment Management, Inc.
1.75% · 11.13M 股
UBS Asset Management
1.33% · 8.47M 股
条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 45次买入 · 5次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Michel Khalaf | Chief Executive Officer | 0.09% |
| John McCallion | Chief Financial Officer | 0.04% |
| Ramy Tadros | President of U.S. Business | 0.03% |
| Marlene Debel | Executive Vice President | 0.02% |
| Bill Pappas | Executive VP and Head of Global Technology & Operations | 0.01% |
| Carlos Gutierrez | Independent Director | 0.01% |
| Edward Kelly | Independent Director | 0.01% |
| Denise Morrison | Independent Director | 0.01% |
| David Herzog | Independent Director | 0.00% |
| Diana McKenzie | Independent Director | 0.00% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-30 | William Kennard | Independent Director | Other Acquisition | +544 | $94.35 |
| 2026-09-30 | Christian Mumenthaler | Independent Director | Other Acquisition | +544 | $94.35 |
| 2026-09-30 | Daniel Glaser | Director | Other Acquisition | +544 | $94.35 |
| 2026-09-30 | Michelle Seitz | Director | Other Acquisition | +544 | -- |
| 2026-09-30 | Carla Harris | Independent Director | Other Acquisition | +544 | $94.35 |
| 2026-09-30 | Robert Glenn Hubbard | Independent Chairperson | Other Acquisition | +941 | $94.35 |
| 2026-09-30 | Diana McKenzie | Independent Director | Other Acquisition | +544 | $94.35 |
| 2026-09-30 | Mark Weinberger | Independent Director | Other Acquisition | +544 | -- |
| 2026-09-30 | Jeh Johnson | Independent Director | Other Acquisition | +544 | $94.35 |
| 2026-09-30 | Laura Hay | Director | Other Acquisition | +544 | $94.35 |
| 2026-09-07 | William Kennard | Independent Director | Other Acquisition | +294 | $95.50 |
| 2026-09-07 | Christian Mumenthaler | Independent Director | Other Acquisition | +21 | $95.50 |
| 2026-09-07 | Daniel Glaser | Director | Other Acquisition | +10 | $95.50 |
| 2026-09-07 | Carla Harris | Independent Director | Other Acquisition | +42 | $95.50 |
| 2026-09-07 | Robert Glenn Hubbard | Independent Chairperson | Other Acquisition | +618 | $95.50 |
| 2026-09-07 | Diana McKenzie | Independent Director | Other Acquisition | +157 | $95.50 |
| 2026-09-07 | Jeh Johnson | Independent Director | Other Acquisition | +59 | $95.50 |
| 2026-09-07 | Ramy Tadros | President of U.S. Business | Other Acquisition | +115 | $95.50 |
| 2026-09-07 | Laura Hay | Director | Other Acquisition | +39 | $95.50 |
| 2026-08-30 | Marlene Debel | Executive Vice President | Sale to Issuer | -4,030 | $95.17 |
Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
大都会人寿 讨论区 0 条评论